Flurry of cannabis M&A that followed Trump marijuana rescheduling a sign of things to come
A flurry of cannabis business transactions came on the heels of President Donald Trump's Dec. 18 executive order…
News January 14
Latest In: Finance
Big banks still refusing cannabis despite Trump marijuana rescheduling
Big U.S. banks are still refusing to do business with the $32 billion legal cannabis industry despite President…
News January 9
Republican opposition to Trump marijuana rescheduling could thwart other reforms
Republican opposition to President Donald Trump's marijuana rescheduling executive order complicates the picture for future reforms like banking…
News January 6
Is 280E tax relief immediate? Your top marijuana rescheduling questions answered
Marijuana rescheduling doesn't go into effect overnight, and many questions are left unanswered. But MJBizDaily tries to answer…
News January 2
What cannabis investors should watch for in 2026 after marijuana rescheduling
Cannabis investors need to know marijuana rescheduling by itself won't create conditions for a 2026 moonshot.
News December 26
Credit cards, advertising and more: Cannabis rescheduling means business opportunities
With President Donald Trump’s executive order to reschedule marijuana, operators in the $32 billion cannabis industry are anticipating…
News December 23
Marijuana MSO Curaleaf’s Virginia expansion unravels amid more lucrative offer
The Cannabist Co. will sell its Virginia medical marijuana permit for $130 million plus a $30 million lease…
News December 22
Why marijuana rescheduling is a real shift, but not the finish line
Marijuana rescheduling is an enormous win and a transformative shift, but it won't make business easier overnight, our…
News December 19
President Trump reschedules marijuana, moves for Medicare to cover CBD
President Donald Trump moved federal marijuana reform forward with an executive order rescheduling cannabis as a less dangerous…
News December 18
Cannabis MSO Vireo bets on Colorado with $49 million acquisition
Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million…
News December 17
Latest Sponsored
